Pharmaceutical

Syndicate content
Updated: 8 weeks 6 days ago

Novartis Receives European Approval for Eye-Care Drug Jetrea

Mon, 03/18/2013 - 17:23

European approval has been received for a drug named `Jetrea' by the eye care division Alcon of Novartis AG.


read more

Cangrelor Better than Plavix, Study

Mon, 03/11/2013 - 17:52

In a new study released this Sunday, cangrelor has proved better as anti-clotting drug than the most commonly used drug for the purpose, plavix.


read more

Merck Has Named Roger Perlmutter New Research Head

Fri, 03/08/2013 - 19:44

According to a new news report, Merck has finally named a new head of Research. Roger Perlmutter is now the new executive vice president and president of Merck Research Laboratories.


read more

GSK Files for Albiglutide’s Approval

Fri, 03/08/2013 - 13:10

The European Medicines Agency (EMA) recently received a marketing authorization application (MAA) by pharmaceutical giant GlaxoSmithKline (GSK).


read more

Company Brags Unapproved Drug Benefits

Wed, 03/06/2013 - 17:36

For the first time, seemingly, such kind of high-concentration sales push was there to be seen. It is being said that the aim was to guarantee results.


read more

Sun Pharmaceutical Stocks Climb after FDA Approval

Tue, 02/05/2013 - 16:16

After an approval by the U. S. Food and Drug Administration (USFDA) for the generic version of the cancer drug Doxil, Sun Pharmaceutical Industries is active in the trade market.


read more

GSK Signs Agreement with Biological-E for Six-in-One Polio Vaccine

Tue, 01/29/2013 - 17:51

GlaxoSmithKline (GSK), the world's fourth largest drug maker, has entered into an equal joint venture agreement with Biological-E Ltd., a vaccines company based in Hyderabad, recently.


read more

Diane-35 a Suitable Treatment for Severe Acne, Not Birth Control

Tue, 01/29/2013 - 15:20

In last 25 years, around four deaths have been linked with the use of acne drug Diane-35, which is also used as a contraceptive pill.


read more

FDA Approves Fulyzaq for Diarrhea in HIV/AIDS Patients

Thu, 01/03/2013 - 17:45

A recent news has certainly given relief to those HIV/AIDS patients with diarrhea as the U. S. Food and Drug Administration has given approval for Fulyzaq on Monday.


read more

Eli Lilly’s Tabalumab Fails over Efficacy in Phase 3 Trial

Fri, 12/14/2012 - 17:23

Though, tabalumab's Phase II clinical studies showed success and proved effective, a recent report has revealed that Eli Lilly and Company's human monoclonal antibody failed in terms of meeting effica


read more

Lilly All Set To Conduct another Successful Trial of Alzheimer's Drug

Thu, 12/13/2012 - 13:49

A recent research has shed light on an experimental Alzheimer's drug, by Eli Lilly & Company, which might be able to deal with the mild cases.


read more

FrenchTribune Specials